Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial) (opens ClinicalTrials.gov)
- Sponsor
- Instituto Mexicano del Seguro Social
- Enrolment
- 44
- Started
- 2025-12-30
- Last update
- 2026-11-04
Conditions: Acute Myocardial Infarction With ST Elevation
Interventions: Dapagliflozin 10 MG Oral Tablet, Semaglutide (Rybelsus®)